Amplification of chromosome 5p correlates with increased expression of Skp2 in HPV-immortalized keratinocytes

被引:29
作者
Dowen, SE
Neutze, DM
Pett, MR
Cottage, A
Stern, P
Coleman, N
Stanley, MA
机构
[1] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[2] MRC, Res Ctr, Cambridge CB2 2QH, England
[3] Christie Hosp NHS Trust, Canc Res UK, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England
关键词
5p; HPV; SKP2; p27;
D O I
10.1038/sj.onc.1206296
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncogenic HPVs immortalize primary genital keratinocytes in vitro and there is evidence that such lines represent suitable models to examine HPV-induced carcinogenesis. Early in vivo studies and more recent CGH analyses have revealed amplification of chromosome 5p in advanced stage carcinoma of the uterine cervix (CaCx). In the present study, a panel of established CaCx-derived cell tines were analysed by M-FISH to identify recurrent karyotypic abnormalities. Amplification of 5p was observed in I I of 13 CaCx cell lines harbouring HR (high-risk) HPV. The region of 5p undergoing amplification was confirmed using human band-specific paints. The F-box protein Skp2 is present at 5p13 and its protein is present at increased levels in many cancers of an advanced stage. The HPV16-harbouring cell line W12 shows progressive morphological abnormality with in vitro passage, culminating in an invasive phenotype. The expression of Skp2 at different stages of this progression was investigated utilizing Western blot and TaqMan quantitative PCR. At medium to late passage, gain of 5p as an isochromosome was observed. Increased expression of Skp2 and a reduction in the expression of its target p27 correlated with increasing passage in this line.
引用
收藏
页码:2531 / 2540
页数:10
相关论文
共 61 条
[1]   NONRANDOM CHROMOSOME CHANGES IN CARCINOMA OF THE CERVIX UTERI .1. 9 NEAR-DIPLOID TUMORS [J].
ATKIN, NB ;
BAKER, MC .
CANCER GENETICS AND CYTOGENETICS, 1982, 7 (03) :209-222
[2]   NONRANDOM CHROMOSOME CHANGES IN CARCINOMA OF THE CERVIX UTERI .2. 10 TUMORS IN THE TRIPLOID TETRAPLOID RANGE [J].
ATKIN, NB ;
BAKER, MC .
CANCER GENETICS AND CYTOGENETICS, 1984, 13 (03) :189-207
[3]  
Aubele M, 1998, CANCER CYTOPATHOL, V84, P375, DOI 10.1002/(SICI)1097-0142(19981225)84:6<375::AID-CNCR10>3.0.CO
[4]  
2-1
[5]  
AUERSPERG N, 1964, J NATL CANCER I, V32, P135
[6]   Multiple mechanisms underlie HLA dysregulation in cervical cancer [J].
Brady, CS ;
Bartholomew, JS ;
Burt, DJ ;
Duggan-Keen, MF ;
Glenville, S ;
Telford, N ;
Little, AM ;
Davidson, JA ;
Jimenez, P ;
Ruiz-Cabello, F ;
Garrido, F ;
Stern, PL .
TISSUE ANTIGENS, 2000, 55 (05) :401-411
[7]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[8]   Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression [J].
Carrano, AC ;
Pagano, M .
JOURNAL OF CELL BIOLOGY, 2001, 153 (07) :1381-1389
[9]  
Ciaparrone M, 1998, CANCER RES, V58, P114
[10]  
Cottage A, 2001, GENE CHROMOSOME CANC, V30, P72, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1060>3.0.CO